Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study
BRAVE
1 other identifier
interventional
4,000
1 country
1
Brief Summary
The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 17, 2021
CompletedFirst Submitted
Initial submission to the registry
July 13, 2021
CompletedFirst Posted
Study publicly available on registry
July 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedJuly 15, 2021
July 1, 2021
1.1 years
July 13, 2021
July 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Increase in COVID-19 testing
Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get tested for COVID-19.
1 month
Increase in COVID-19 vaccination
Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get vaccinated against COVID-19.
1 month
Study Arms (2)
BRAVE Non-Intervention
NO INTERVENTIONSurvey participants in the BRAVE non-intervention arm will not have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.
BRAVE Intervention
ACTIVE COMPARATORSurvey participants in the BRAVE intervention arm will have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.
Interventions
This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.
Eligibility Criteria
You may qualify if:
- \- Self reports as Native American or American Indian
You may not qualify if:
- Does not self-report as Native American or American Indian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- North Carolina Central Universitylead
- Lumbee Tribe of North Carolinacollaborator
- University of North Carolina at Pembrokecollaborator
Study Sites (1)
Lumbee Tribe Tribal Housing Complex
Pembroke, North Carolina, 28372, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deepak Kumar, PhD
North Carolina Central University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking employed in this study.
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Julius L. Chambers Biomedical/Biotechnology Research Institute
Study Record Dates
First Submitted
July 13, 2021
First Posted
July 15, 2021
Study Start
February 17, 2021
Primary Completion
March 30, 2022
Study Completion
June 30, 2022
Last Updated
July 15, 2021
Record last verified: 2021-07